Welcome to Dwaey, specifically on Metronidazole 0.75% Vag prep page.
This medicine contains important and useful components, as it consists of
Metronidazole 0.75% Vag prep is available in the market in concentration.
Metronidazole 0.75% Vag prep
Before using Metronidazole 0.75% Vaginal Preparation, patients should consult their healthcare provider to confirm that it is appropriate for their specific condition. Key precautions include:
- Pregnancy: Metronidazole is considered Category B for pregnancy, indicating that it is generally safe but should only be used when necessary. It should be avoided in the first trimester unless prescribed by a healthcare provider, as there is insufficient data to confirm safety during this period.
- Liver Disease: Metronidazole is metabolized in the liver, and caution should be exercised in patients with liver impairment. A dose adjustment may be necessary depending on the severity of liver dysfunction.
- Alcohol Consumption: Metronidazole can cause a disulfiram-like reaction (nausea, vomiting, flushing, and headache) when taken with alcohol. Patients should avoid alcohol during treatment and for at least 48 hours after completing the course.
- Neurological Symptoms: Patients with a history of neurological disorders, including seizures, should use Metronidazole with caution, as it can cause central nervous system effects, including dizziness, headaches, and, rarely, seizures.
- Allergies: Individuals with known hypersensitivity to Metronidazole or other nitroimidazole derivatives should not use this medication. A skin test may be done if an allergy to Metronidazole is suspected.
- Overuse: Prolonged use of this medication should be avoided to reduce the risk of vaginal irritation or overgrowth of non-susceptible organisms.
Metronidazole 0.75% Vaginal Preparation is primarily used for the treatment of bacterial vaginosis (BV), which is a condition caused by an imbalance in the normal vaginal bacteria. This medication is specifically indicated for:
- Bacterial Vaginosis: Metronidazole is effective against the anaerobic bacteria that commonly cause BV, which leads to symptoms such as unusual vaginal discharge, fishy odor, and vaginal itching.
- Mixed Vaginal Infections: It may also be prescribed for the treatment of mixed vaginal infections caused by both aerobic and anaerobic bacteria.
- Postpartum or Post-surgical Infections: Metronidazole may be used to prevent or treat infections following childbirth or vaginal surgeries.
This medication should be avoided in certain cases, including:
- Hypersensitivity: Patients with a known allergy to Metronidazole or other nitroimidazole derivatives should not use this product.
- First Trimester of Pregnancy: The use of Metronidazole is generally contraindicated during the first trimester of pregnancy unless specifically advised by a healthcare provider.
- Severe Liver Dysfunction: Metronidazole is metabolized in the liver, and its use is contraindicated in patients with severe liver impairment due to the risk of toxicity.
- Alcohol Use: As Metronidazole can cause severe reactions with alcohol (disulfiram-like reaction), it should be avoided in patients who are consuming alcohol or are in recovery from alcohol use.
- Blood Disorders: Metronidazole should be used cautiously in patients with blood disorders, such as leukopenia, as it may affect white blood cell counts.
Common and severe side effects associated with Metronidazole 0.75% Vaginal Preparation include:
- Local Irritation: Mild vaginal burning, itching, or discomfort may occur upon initial use.
- Vaginal Discharge: An increase in vaginal discharge is possible. Patients should report if the discharge becomes foul-smelling or abnormal in texture.
- Systemic Effects: Though rare with topical use, some individuals may experience headache, dizziness, or nausea, which are more common with oral Metronidazole use.
- Dryness or Redness: Vaginal dryness or redness at the application site may occur, which can be managed by reducing the frequency of application or discontinuing use if severe.
- Taste Disturbance: Although more common with oral forms, some users may report a metallic taste when using Metronidazole vaginally.
- Systemic Allergic Reactions: Rare, but some patients may experience skin rashes, itching, or more severe allergic reactions like swelling, difficulty breathing, or anaphylaxis. Any of these should be reported immediately.
2
Metronidazole works by inhibiting DNA synthesis in anaerobic bacteria and protozoa. Specifically, it:
- Disrupts DNA: Metronidazole enters the bacteria and, through a reduction process, creates reactive metabolites that interact with bacterial DNA, leading to strand breakage and inhibition of DNA replication. This prevents the anaerobic bacteria from multiplying and helps eliminate the infection.
- Targets Anaerobic Bacteria: Metronidazole is particularly effective against anaerobic microorganisms, including those commonly responsible for bacterial vaginosis (e.g., *Gardnerella vaginalis*, *Bacteroides*, *Prevotella*).
- Selective Action: It has little to no activity against aerobic bacteria, which is why it is typically combined with other antimicrobial agents for mixed infections. This makes it effective specifically for bacterial vaginosis, which is typically caused by a combination of anaerobic bacteria and a reduction in lactobacilli.
Metronidazole 0.75% Vaginal Preparation may interact with other medications and substances, including:
- Alcohol: Metronidazole can cause a disulfiram-like reaction with alcohol, leading to flushing, headache, nausea, and vomiting. Patients should refrain from consuming alcohol during treatment and for 48 hours after discontinuing the medication.
- Warfarin: Metronidazole can potentiate the anticoagulant effect of warfarin, increasing the risk of bleeding. Regular monitoring of INR is recommended when used together.
- Corticosteroids: Metronidazole can enhance the effects of corticosteroids, leading to potential side effects such as Cushing's syndrome or fluid retention. Caution is advised when using these medications together.
- Lithium: Metronidazole may increase the blood levels of lithium, potentially leading to lithium toxicity. Monitoring of lithium levels is recommended during concomitant use.
- Cyclosporine: Co-administration of Metronidazole and cyclosporine may increase the risk of toxicity due to increased cyclosporine levels.
- CYP450 Inhibitors: Since Metronidazole is metabolized by the CYP450 system, inhibitors of this enzyme system (e.g., fluconazole, ketoconazole) may increase Metronidazole levels and enhance its effects or side effects.
For adult females, the recommended dose of Metronidazole 0.75% Vaginal Preparation is:
- Insert 1 applicator full (approximately 5 grams) into the vagina once daily, usually at bedtime, for a 7-day treatment course.
- In certain cases, the healthcare provider may adjust the duration of therapy based on the severity of the infection.
The use of Metronidazole 0.75% Vaginal Preparation in children has not been well studied and is generally not recommended unless specifically prescribed by a healthcare provider. The safety and efficacy of this treatment for pediatric patients have not been established, and alternative treatments should be considered for children, especially those who are prepubescent.
It is important to consult a healthcare provider before starting this medication to ensure it is appropriate for the specific infection and that the patient is well-suited for treatment.
For patients with renal impairment, Metronidazole 0.75% Vaginal Preparation should be used with caution. While systemic absorption from vaginal use is minimal, patients with severe renal dysfunction should still consult their healthcare provider. Adjustments may be necessary, especially for patients also taking systemic Metronidazole or other medications that affect kidney function.
Not available in a medicine form yet